What are nanoplatforms primarily designed for in targeted therapy?

Nanoplatforms are specifically designed to serve as carriers for delivering therapeutic agents to target cells in the context of targeted therapy. This design is central to their function, as they can be engineered to interact with specific cell types or tissues, allowing for precision in drug delivery. By utilizing nanoplatforms, therapies such as cancer treatments can increase the efficacy of the drugs while minimizing side effects by directing the therapeutic agents precisely to the intended site of action.

The ability of nanoplatforms to encapsulate drugs and control their release also enhances the therapeutic window, offering an improved treatment outcome. Nanotechnology allows for the manipulation of materials at the molecular level, leading to optimal interactions with biological systems.

In contrast, nanoscale carriers aimed at food flavor enhancement, electronic device components, or supports in industrial chemical processes do not pertain to the realm of targeted therapy. These applications focus on different objectives that do not involve the therapeutic delivery mechanisms central to the function of nanoplatforms in medical treatments.